Welcome to our dedicated page for RTX SEC filings (Ticker: RTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RTX Corporation filings document regulatory disclosures for an aerospace and defense operating company with NYSE-listed common stock and 2.150% notes due 2030. Recent 8-K reports furnish operating and financial results, capital-structure information and material-event updates, including disclosure about MUSE passenger processing software systems.
Proxy and annual meeting filings cover director elections, shareowner voting matters and board composition. Other material-event reports record governance changes, registered securities and cybersecurity-related disclosures within RTX's formal public-company reporting record.
RTX Corporation – Form 144 notice
The filer intends to sell up to 8,704 RTX common shares on the NYSE through UBS Financial Services around 24 Jul 2025. At the reference price the stake is worth roughly $1.36 million and equals only about 0.00065 % of the 1,338,541,827 shares outstanding. The stock was obtained via RSU grants dated 13 Feb 2018 (3,000 sh), 30 Jan 2022 (4,737 sh) and 8 Feb 2024 (967 sh), each paid for by wire transfer. The filer states no sales occurred in the prior three months and certifies possession of no undisclosed material adverse information, meeting Rule 144 requirements.
This Form 144 filing discloses that an unidentified insider plans to sell 1,462 RTX Corporation common shares through UBS Financial Services on or about 23 July 2025. The shares stem from RSU vesting on 15 Feb 2025. Estimated aggregate market value of the planned sale is $222,595, versus ≈1.34 billion total shares outstanding. No prior insider sales were reported in the last three months, and the filer attests to possessing no undisclosed adverse information. No additional financial data, performance metrics or company-level developments are included.